Nightfood Holdings Inc. (OTCQB: NGTF) announced that its subsidiary, TechForce Robotics, has successfully completed Phase 1 objectives under its joint development agreement with Oncotelic Therapeutics (OTCQB: OTLC), highlighted by the initial deployment of LIM-E, an autonomous laboratory support robot. The deployment marks TechForce's first expansion into pharmaceutical and laboratory automation and validates the adaptability of its AI-enhanced robotics platform beyond hospitality and service-industry applications into life sciences and pharmaceutical environments.
TechForce said the deployment completed the initial operational goals established under the companies' April 2026 collaboration agreement and will provide operational data and workflow insights to support future automation initiatives. The companies plan to continue evaluating opportunities in laboratory logistics, manufacturing support, AI-enhanced workflows and other automation applications, while Nightfood views healthcare, life sciences and pharmaceutical manufacturing as significant long-term growth markets for its Robotics-as-a-Service platform.
This milestone is important because it demonstrates the cross-industry potential of TechForce's automation technology. By moving from hospitality into the highly regulated pharmaceutical sector, TechForce opens up a large addressable market. For the pharmaceutical industry, autonomous robots like LIM-E can improve efficiency, reduce human error, and enhance consistency in laboratory workflows. This could accelerate drug development and manufacturing processes, potentially leading to faster time-to-market for new therapies.
For investors, this deployment signals that Nightfood's RaaS model is gaining traction in new verticals, which could diversify revenue streams and reduce reliance on any single industry. The collaboration with Oncotelic, a clinical-stage biopharmaceutical company focused on oncology, also provides a real-world testing ground for robotics in life sciences. If successful, this could lead to broader adoption across the pharmaceutical supply chain.
Nightfood's subsidiary TechForce Robotics develops and deploys autonomous robotic systems designed to improve operational efficiency, workflow consistency, and scalability across multiple industries. The company combines advanced hardware, intelligent AI-enhanced software, and scalable operational infrastructure to support long-term growth through its RaaS model. For more information about Nightfood, visit www.nightfoodholdings.com. For more about TechForce Robotics, see www.techforcerobotics.com. The full press release is available at https://ibn.fm/RFkfL.
